International Scholarly Research Notices / 2011 / Article / Tab 1

Clinical Study

A Comprehensive Study of Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease

Table 1

Profiles of 12 PD patients.

Case Sex Age
(years)
Disease
duration
(years)
Modified Hoehn and Yah Stage (1) Schwab and England ADLScale (1) L-DOPA (2) (mg) D2 agonists (3) Amantadine
(mg)
Droxydopa
(mg)
Trihexi-phenidyl (mg) Other drugs
Drugs Dosage (mg)

1Man571380%300*CB1000Maprotiline,
flunitrazepam
2Man6713360%300BC7.51503004
3Woman7082.580%300none03000
4Man6662.580%300PG0.31006004
5Man6492.580%400BC1502004
6Woman7614370%500BC105000Imipramine,
flurazepam
7Man7311450%400PG109000Imipramine,
clonazepam
8Woman692380%300PG0.106000
9Woman75122.560%300PG0.7510000
10Man7812430%400PG0.75506000Mitodrine
11Man6742.590%450PG0.75006
12Woman6810280%450BC15006

(1) Under the drug-off state at before sham rTMS.
(2) Levodopa-carbidopa combination. *Levodopa-benserazide combination.
(3) CB: cabergolin, BC: bromocriptine, PG: pergolide.